Login
Toggle navigation
Videos
Categories
Trending
Aram Mangasarian , CEO, NOXXON Pharma
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
NOXXON PHARMA - Interview with CEO Aram MANGASARIAN
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Liv from Severn Trent Water shares insights at the upcoming industry event on April 20-21, 2016, at the Royal venue.
00:10:00
June 2024 Fund Performance Insights | Omar Abdalla - Member of Investment team at Alaska Investimentos
00:10:00
Marathon Asset Management CEO Bruce Richards offers investment insights and discusses global market influences on Closing Bell.
00:10:00
Nucor Gold: Advancing Exploration with 90,000 Meters Drilled in Ghana
00:10:00
Unveiling the Power of Value Chain Partnerships: Insights from Christine Straughn | Kevin J. Kwilinski - Chief Executive Officer of Berry Global
00:10:00
American Creek Resources Secures Joint Ventures to Advance Gold and Silver Projects in BC's Golden Triangle
00:10:00
ONE Gas CEO provides insight on the company's evolution and the future of natural gas in an interview with Tulsa World.
00:10:00
Cultivating Generosity: Lessons from Chris and Kim Patton | BlueTrust Insights
00:10:00
Roku CEO Anthony Wood expressed increased confidence in the company's business following the results.
00:10:00
Cohort plc Leaders Discuss Interim Results and Global Geopolitical Landscape | Andrew Thomis - CEO of cohort plc
00:10:00
Understanding Industrial Investments: Analyst Melanie Rizzo Discusses the Impact of Government Policies on the Business Cycle for T. Rowe Price
00:10:00
Roger Ailes: Revolutionizing American Cable News|Roger Ailes